The Clinical Profile of Severe Pediatric Malaria in an Area Targeted for Routine RTS,S/AS01 Malaria Vaccination in Western Kenya
- PMID: 31504308
- PMCID: PMC7353324
- DOI: 10.1093/cid/ciz844
The Clinical Profile of Severe Pediatric Malaria in an Area Targeted for Routine RTS,S/AS01 Malaria Vaccination in Western Kenya
Abstract
Background: The malaria prevalence has declined in western Kenya, resulting in the risk of neurological phenotypes in older children. This study investigates the clinical profile of pediatric malaria admissions ahead of the introduction of the RTS,S/AS01 vaccine.
Methods: Malaria admissions in children aged 1 month to 15 years were identified from routine, standardized, inpatient clinical surveillance data collected between 2015 and 2018 from 4 hospitals in western Kenya. Malaria phenotypes were defined based on available data.
Results: There were 5766 malaria admissions documented. The median age was 36 months (interquartile range, 18-60): 15% were aged between 1-11 months of age, 33% were aged 1-23 months of age, and 70% were aged 1 month to 5 years. At admission, 2340 (40.6%) children had severe malaria: 421/2208 (19.1%) had impaired consciousness, 665/2240 (29.7%) had an inability to drink or breastfeed, 317/2340 (13.6%) had experienced 2 or more convulsions, 1057/2340 (45.2%) had severe anemia, and 441/2239 (19.7%) had severe respiratory distress. Overall, 211 (3.7%) children admitted with malaria died; 163/211 (77% deaths, case fatality rate 7.0%) and 48/211 (23% deaths, case fatality rate 1.4%) met the criteria for severe malaria and nonsevere malaria at admission, respectively. The median age for fatal cases was 33 months (interquartile range, 12-72) and the case fatality rate was highest in those unconscious (44.4%).
Conclusions: Severe malaria in western Kenya is still predominantly seen among the younger pediatric age group and current interventions targeted for those <5 years are appropriate. However, there are increasing numbers of children older than 5 years admitted with malaria, and ongoing hospital surveillance would identify when interventions should target older children.
Keywords: Kenya; admissions; children; malaria; severe.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures



Comment in
-
Waiting for the Malaria Vaccine: The Complex Epidemiological Transition Toward Malaria Elimination.Clin Infect Dis. 2020 Jul 11;71(2):381-382. doi: 10.1093/cid/ciz847. Clin Infect Dis. 2020. PMID: 31504320 No abstract available.
Similar articles
-
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.Lancet Infect Dis. 2016 Oct;16(10):1134-1144. doi: 10.1016/S1473-3099(16)30161-X. Epub 2016 Jul 7. Lancet Infect Dis. 2016. PMID: 27394191 Free PMC article. Clinical Trial.
-
Feasibility, safety, and impact of the RTS,S/AS01E malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.Lancet. 2024 Apr 27;403(10437):1660-1670. doi: 10.1016/S0140-6736(24)00004-7. Epub 2024 Apr 4. Lancet. 2024. PMID: 38583454 Free PMC article. Clinical Trial.
-
Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.Lancet Infect Dis. 2019 Aug;19(8):821-832. doi: 10.1016/S1473-3099(19)30300-7. Epub 2019 Jul 9. Lancet Infect Dis. 2019. PMID: 31300331 Clinical Trial.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
[The RTS,S/AS01 malaria vaccine in children aged 5-17 months at first vaccination].Pan Afr Med J. 2018 Jun 19;30:142. doi: 10.11604/pamj.2018.30.142.13152. eCollection 2018. Pan Afr Med J. 2018. PMID: 30374388 Free PMC article. Review. French.
Cited by
-
Hospital-based surveillance of severe paediatric malaria in two malaria transmission ecological zones of Burkina Faso.Malar J. 2023 Jan 6;22(1):6. doi: 10.1186/s12936-022-04433-x. Malar J. 2023. PMID: 36609299 Free PMC article.
-
Malaria infection and severe disease risks in Africa.Science. 2021 Aug 20;373(6557):926-931. doi: 10.1126/science.abj0089. Science. 2021. PMID: 34413238 Free PMC article.
-
Impact of high human genetic diversity in Africa on immunogenicity and efficacy of RTS,S/AS01 vaccine.Immunogenetics. 2023 Jun;75(3):207-214. doi: 10.1007/s00251-023-01306-8. Epub 2023 Apr 21. Immunogenetics. 2023. PMID: 37084013 Free PMC article. Review.
-
Malaria vaccine coverage estimation using age-eligible populations and service user denominators in Kenya.Malar J. 2023 Sep 27;22(1):287. doi: 10.1186/s12936-023-04721-0. Malar J. 2023. PMID: 37759277 Free PMC article.
-
Predictors of health workers' knowledge about artesunate-based severe malaria treatment recommendations in government and faith-based hospitals in Kenya.Malar J. 2020 Jul 23;19(1):267. doi: 10.1186/s12936-020-03341-2. Malar J. 2020. PMID: 32703215 Free PMC article.
References
-
- World Health Organization. World malaria report 2018 Available at: https://www.who.int/malaria/publications/world-malaria-report-2018/repor.... Accessed 11 March 2019.
-
- World Health Organization. Global technical strategy for malaria 2016–2030 Available at: https://apps.who.int/iris/bitstream/handle/10665/176712/9789241564991_en.... Accessed 11 March 2019.
-
- PMI. U.S. President’s Malaria Initiative Kenya: malaria operational plan FY 2018 Available at: https://www.pmi.gov/docs/default-source/default-document-library/malaria.... Accessed 11 March 2019.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous